1022 related articles for article (PubMed ID: 10611990)
1. A comparison of the onset of protection induced by Newcastle disease virus strain B1 and a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge.
King DJ
Avian Dis; 1999; 43(4):745-55. PubMed ID: 10611990
[TBL] [Abstract][Full Text] [Related]
2. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
Kapczynski DR; King DJ
Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
[TBL] [Abstract][Full Text] [Related]
3. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies.
Morgan RW; Gelb J; Pope CR; Sondermeijer PJ
Avian Dis; 1993; 37(4):1032-40. PubMed ID: 8141730
[TBL] [Abstract][Full Text] [Related]
4. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of the B-1 and VG/GA vaccine strains against velogenic viscerotropic Newcastle disease virus in chickens.
Beard CW; Villegas P; Glisson JR
Avian Dis; 1993; 37(1):222-5. PubMed ID: 8452500
[TBL] [Abstract][Full Text] [Related]
6. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein.
Morgan RW; Gelb J; Schreurs CS; Lütticken D; Rosenberger JK; Sondermeijer PJ
Avian Dis; 1992; 36(4):858-70. PubMed ID: 1485872
[TBL] [Abstract][Full Text] [Related]
7. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a recombinant fowl pox-based Newcastle disease virus vaccine candidate against velogenic and respiratory challenge.
Taylor J; Christensen L; Gettig R; Goebel J; Bouquet JF; Mickle TR; Paoletti E
Avian Dis; 1996; 40(1):173-80. PubMed ID: 8713031
[TBL] [Abstract][Full Text] [Related]
9. Vaccination against Newcastle disease with a recombinant baculovirus hemagglutinin-neuraminidase subunit vaccine.
Nagy E; Krell PJ; Dulac GC; Derbyshire JB
Avian Dis; 1991; 35(3):585-90. PubMed ID: 1953580
[TBL] [Abstract][Full Text] [Related]
10. Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens.
Heckert RA; Riva J; Cook S; McMillen J; Schwartz RD
Avian Dis; 1996; 40(4):770-7. PubMed ID: 8980804
[TBL] [Abstract][Full Text] [Related]
11. Viscerotropic velogenic Newcastle disease in turkeys: immune response following vaccination with either viable B1 strain or inactivated vaccine.
Boney WA; Stone HD; Gillette KG; Coria MF
Avian Dis; 1975; 19(1):19-30. PubMed ID: 1120031
[TBL] [Abstract][Full Text] [Related]
12. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
Miller PJ; King DJ; Afonso CL; Suarez DL
Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
[TBL] [Abstract][Full Text] [Related]
13. Protection in specific pathogen free chickens with live avian metapneumovirus and Newcastle disease virus vaccines applied singly or in combination.
Ganapathy K; Cox WJ; Gough RE; Cargill P; Montiel E; Jones RC
Avian Pathol; 2007 Aug; 36(4):313-7. PubMed ID: 17620178
[TBL] [Abstract][Full Text] [Related]
14. Viscerotropic velogenic Newcastle disease in Turkeys: virus shedding and persistence of infection in susceptible and vaccinated poults.
Gillette KG; Coria MF; Boney WA; Stone HD
Avian Dis; 1975; 19(1):31-9. PubMed ID: 1120035
[TBL] [Abstract][Full Text] [Related]
15. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens.
Reddy SK; Sharma JM; Ahmad J; Reddy DN; McMillen JK; Cook SM; Wild MA; Schwartz RD
Vaccine; 1996 Apr; 14(6):469-77. PubMed ID: 8782342
[TBL] [Abstract][Full Text] [Related]
16. Recombinant paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease.
Swayne DE; Suarez DL; Schultz-Cherry S; Tumpey TM; King DJ; Nakaya T; Palese P; Garcia-Sastre A
Avian Dis; 2003; 47(3 Suppl):1047-50. PubMed ID: 14575108
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a commercial Newcastle vaccine against velogenic viscerotropic Newcastle disease virus.
Benson HN; Wenger DR; Beard PD
Avian Dis; 1975; 19(3):566-72. PubMed ID: 1164321
[TBL] [Abstract][Full Text] [Related]
18. Protective immunity against Newcastle disease: the role of antibodies specific to Newcastle disease virus polypeptides.
Reynolds DL; Maraqa AD
Avian Dis; 2000; 44(1):138-44. PubMed ID: 10737654
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of combined killed-in-oil emulsion and live Newcastle disease vaccines in chickens.
Folitse R; Halvorson DA; Sivanandan V
Avian Dis; 1998; 42(1):173-8. PubMed ID: 9533096
[TBL] [Abstract][Full Text] [Related]
20. Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels.
Sarfati-Mizrahi D; Lozano-Dubernard B; Soto-Priante E; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
Avian Dis; 2010 Mar; 54(1 Suppl):239-41. PubMed ID: 20521638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
